Macular Degeneration (ARMD) wet and dry

Understanding Age-Related Macular Degeneration (ARMD)

Age-related macular degeneration (ARMD) is a condition that specifically impacts the macula, the part of the eye responsible for central vision. To understand the clinical application of coMra therapy in this context, we examine the case of a 95-year-old female patient diagnosed with ARMD.

Prior to her treatment, the patient had experienced a significant deterioration in both visual acuity and overall quality of life over a five-year period. Her medical history included cataract surgery in 2006, during which both lenses were replaced. A diagnosis of ARMD was confirmed via fluorescein angiography, which revealed wet macular degeneration in the right eye and dry macular degeneration in the left eye. At the start of care, her visual acuity was measured as "count fingers" at two meters (six feet) in the right eye, and 20/70 in the left eye.

The Treatment Protocol

The patient underwent a course of eight treatments over a two-month period, with each session lasting approximately 30 minutes. The clinical approach utilized the Neurology 14 protocol, administered via the Delta 905 professional model. Additionally, a microcurrent protocol was integrated into the treatment plan to address concurrent symptoms of depression.

Clinical Results and Visual Improvement

A follow-up examination was conducted one month after the completion of the eight treatments. The results demonstrated significant improvements in both eyes.

In the left eye, which presented with dry macular degeneration, visual acuity improved from 20/70 to 20/50. This represents a movement of one full line down the standard eye chart. Dr. Pena noted that this is a highly significant improvement in vision, particularly given that no other ophthalmic treatments for ARMD were administered during this period.

The right eye, which presented with the more severe wet macular degeneration, also showed remarkable progress. Having started at a baseline of "count fingers" at six feet, the patient’s post-treatment acuity reached 20/400. While this level of vision does not register on a standard eye chart, it is measurable on a low-vision chart. This transition represents a functional shift from being unable to discern shapes at that distance to being able to clearly identify letters at the 20/400 level.

About Dr. Pena

This case study was provided by Dr. Pena, an ophthalmologist specializing in cataract and refractive surgery. Dr. Pena is deeply involved in public health and integrates a holistic approach into his practice, combining homeopathy and traditional Chinese medicine with modern technology. He incorporates both microcurrent and coMra therapy into the treatment of various ocular conditions and has authored several books in Spanish on the subject of holistic health.